Bültmann & Gerriets
Advances in Oncology, 2024, E-Book
von Ph. D Platanias M. D.
Verlag: Elsevier HealthScience EN
E-Book / EPUB
Kopierschutz: ePub mit Wasserzeichen

Hinweis: Nach dem Checkout (Kasse) wird direkt ein Link zum Download bereitgestellt. Der Link kann dann auf PC, Smartphone oder E-Book-Reader ausgeführt werden.
E-Books können per PayPal bezahlt werden. Wenn Sie E-Books per Rechnung bezahlen möchten, kontaktieren Sie uns bitte.

ISBN: 978-0-443-24701-9
Erschienen am 10.04.2024
Sprache: Englisch
Umfang: 240 Seiten

Preis: 148,99 €

148,99 €
merken
zum Hardcover 217,50 €
Klappentext
Inhaltsverzeichnis

Advances in Oncology reviews the year's most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
- Contains 26 articles on such topics as management of locoregional melanoma; surgery for recurrent ovarian cancer; advances in pediatric cancer with big data: the Pediatric Cancer Data Commons; advanced imaging in gliomas; approach to minimal residual disease for acute myeloid leukemia; treatment options for HER2-expressing gastroesophageal cancers; and more.
- Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice.
- Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.



Contemporary Management of Dermatofibrosarcoma ProtuberansManagement of Locoregional MelanomaCurrent Management of Intraductal Papillary Mucinous NeoplasmsPerioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted TherapyOptimal Front-Line Therapy for Non[1]Oncogene-Driven Non-Small Cell Lung CancerBeyond First-Line Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKI): Approach to ResistanceAntibody-Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical ApplicationSurgery for Recurrent Ovarian CancerBig Data in Pediatric Oncology: Hope, Hype, RealityImipridones and Dopamine Receptor Antagonism in the Therapeutic Management of GliomasDiagnostic and Theranostic Opportunities in Neuro-OncologyUpdates on Revised Diagnostic Criteria and Targeted Therapies for NeurofibromatosisManagement of Relapsed Refractory Large B[1]Cell Non-Hodgkin Lymphoma: Chimeric Antigen Receptor T-Cell Therapy versus Autologous Stem Cell TransplantationT-cell Acute Lymphoblastic Leukemia: Novel Therapies Worth WatchingPrognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid LeukemiaRole of Circulating Tumor DNA for Monitoring of Recurrence and Treatment Response in Urothelial CancerIntensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: Patient Selection and Overview of Doublet and Triplet Therapy DataAdjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future DirectionsDefining the Role of Neoadjuvant Therapy for Gastroesophageal CancersCurrent and Emerging Therapeutic Options for Human Epidermal Growth Factor Receptor 2-Expressing Gastroesophageal CancersContemporary Systemic Therapy Approaches for Unresectable Hepatocellular CarcinomaMultidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma


andere Formate